Evidence map›Paper›PMID 24077438›Full record

ArticleReproductive sciences (Thousand Oaks, Calif.)2014

Effect of dexamethasone administered with magnesium sulfate on inflammation-mediated degradation of the blood-brain barrier using an in vitro model.

Monica A Lutgendorf, Danielle L Ippolito, Mariano T Mesngon, Deborah Tinnemore, Mary Jo Dehart, Brad M Dolinsky, Peter G Napolitano

Open access · bronzeAbstract read
In one paragraph

Article in Reproductive sciences (Thousand Oaks, Calif.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Trial
  2. Current neuropharmacology · 2024
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Monica A Lutgendorf1Department of Obstetrics and Gynecology, Maternal Fetal Medicine, Madigan Army Medical Center, Tacoma, WA, USA.
Danielle L Ippolito
Mariano T Mesngon
Deborah Tinnemore
Mary Jo Dehart
Brad M Dolinsky
Peter G Napolitano
Madigan Army Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients at risk for preterm delivery are frequently administered both antenatal steroids for fetal maturation and magnesium sulfate for neuroprotection. In this study, we investigate whether steroids coadministered with magnesium sulfate preserve blood-brain barrier integrity in neuroinflammation. Human umbilical vein endothelial cells were grown in astroglial conditioned media in a 2-chamber cell culture apparatus. Treatment with tumor necrosis factor-α (TNF-α) or catalytically active recombinant matrix metalloproteinase 9 (MMP-9) simulated neuroinflammation. Membrane integrity was assessed by zona occludens 1 (ZO-1) immunoreactivity, permeability to fluorescently conjugated dextran, and transendothelial electrical resistance (TEER). The TNF-α and MMP-9 treatment increased the rate of dextran transit, decreased TEER, and decreased ZO-1 immunoreactivity at junctional interfaces. Dexamethasone pretreatment alone or in combination with 0.5 mmol/L magnesium sulfate preserved monolayer integrity after inflammatory insult. Magnesium sulfate alone was not protective. This study supports a possible interaction between steroids and magnesium in neuroprotection.

Indexed as

AnimalsAstrocytesBlood-Brain BarrierCapillary PermeabilityCell LineCulture Media, ConditionedDexamethasoneElectric ImpedanceEncephalitisEndothelial CellsGlucocorticoidsHumansInflammation MediatorsMagnesium SulfateMatrix Metalloproteinase 9Neuroprotective AgentsCulture Media, ConditionedDexamethasoneGlucocorticoidsInflammation MediatorsMagnesium SulfateMatrix Metalloproteinase 9Neuroprotective AgentsTJP1 protein, humanTumor Necrosis Factor-alphaZonula Occludens-1 Proteinmagnesiummatrix metalloproteinase 9neuroprotection

Identifiers

PMID24077438
PMCPMC3960840
OpenAlexW2127897419

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.